Vachon M G, Nairn J G
Faculty of Pharmacy, University of Toronto, Ontario, Canada.
J Microencapsul. 1997 May-Jun;14(3):281-301. doi: 10.3109/02652049709051133.
Homogeneous Eudragit RS100 matrix microspheres containing molecularly dispersed acetylsalicylic acid (ASA) were prepared in order to investigate the effect of encapsulation on the decomposition rate of a hydrolytically susceptible drug. ASA-loaded microspheres of this non-eroding polymer matrix were analysed at predetermined time points following immersion of the microspheres in temperature controlled buffer systems at pH 1.2 or pH 12.1 at 30, 40 or 50 degrees C. The mass balance of the total amount of solutes (ASA and SA) initially located within the microsphere interior was equal to the sum of the amount of solutes remaining in the microsphere interior and the amount of solutes in the aqueous phase at any time during the course of the study. Each analysis involved the quantitation of four species; the drug and decomposition product, salicylic acid (SA), in both the microspheres phase and the external aqueous phase. A simple model system using first-order rate approximations for the concurrent Fickian diffusion and hydrolysis decomposition of the drug resulted in a multiexponential expression which adequately described the time-course profile of the drug. SA-loaded microspheres were used as a control under similar conditions to determine the magnitude of the contribution of microsphere phase hydrolysis of ASA to the overall rate of drug loss from the microspheres. Results indicated that microspheres phase hydrolysis of ASA was minimal. Even after 900 h of immersion in pH 12.1 buffer some ASA remained within the microsphere. It is postulated that the matrix incorporated drug is essentially shielded from hydrolytic attack until it is liberated into the external aqueous environment. Electrostatic association of the drug with the charged quaternary residues in the polymer along with the limiting availability of water within the microsphere may be responsible for the observed stability of ASA in aqueous swollen ASA-loaded Eudragit microspheres.
制备了含有分子分散乙酰水杨酸(ASA)的均一型Eudragit RS100基质微球,以研究包封对水解敏感药物分解速率的影响。将这种非侵蚀性聚合物基质的载ASA微球在30、40或50摄氏度下浸入pH 1.2或pH 12.1的温度控制缓冲系统中,在预定时间点进行分析。在研究过程中的任何时间,最初位于微球内部的溶质(ASA和SA)总量的质量平衡等于微球内部剩余溶质的量与水相中溶质的量之和。每次分析都涉及对四种物质的定量;药物及其分解产物水杨酸(SA),分别在微球相和外部水相中。一个使用一级速率近似来描述药物同时进行的菲克扩散和水解分解的简单模型系统产生了一个多指数表达式,该表达式充分描述了药物的时间进程曲线。在类似条件下,将载SA微球用作对照,以确定ASA微球相水解对微球中药物总体损失速率的贡献程度。结果表明,ASA的微球相水解最小。即使在pH 12.1缓冲液中浸泡900小时后,仍有一些ASA保留在微球内。据推测,基质中掺入的药物在释放到外部水环境之前基本上受到水解攻击的保护。药物与聚合物中带电荷的季铵残基的静电缔合以及微球内水的有限可用性可能是观察到的载ASA的Eudragit微球在水溶胀时ASA稳定性的原因。